FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Civica, Inc.)

View source ↗

Summary

FDA approved Civica, Inc.'s original application for Neostigmine Methylsulfate, a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis
• Postoperative Ileus
• Urinary Retention

Drugs mentioned

• Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)